Intra Cellular Therapies reported $20.05M in Sales Revenues for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Acadia Pharmaceuticals ACAD:US $ 115.22M 8.67M
Adamas Pharmaceuticals ADMS:US 21.97M 2.66M
ALKERMES ALKS:US $ 303.72M 52.29M
Aptinyx Inc APTX:US $ 0 1000K
Arena Pharmaceuticals ARNA:US $ 0M 0M
Biocryst Pharmaceuticals BCRX:US $ 49.96M 30.9M
Biogen BIIB:US $ 2775M 81M
Bristol Myers Squibb BMY:US $ 11703M 630M
Cytokinetics CYTK:US $ 2.84M 3.7M
Esperion Therapeutics ESPR:US $ 40.66M 32.68M
Gilead Sciences GILD:US $ 6217M 206M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Halozyme Therapeutics HALO:US $ 136.46M 47.43M
Intra Cellular Therapies ITCI:US $ 20.05M 4.17M
JAZZ PHA JAZZ:US $ 751.81M 144.23M
Johnson & Johnson JNJ:US $ 23312M 991M
Marinus Pharmaceuticals MRNS:US 1.9M 99K
Nektar Therapeutics NKTR:US $ 28.33M 4.68M
Neurocrine Biosciences NBIX:US $ 288.9M 52.3M
Novartis NVS:US $ 13294M 600M
Prothena PRTA:US 60.07M 59.91M
Redhill Biopharma RDHL:US $ 21.5M 0.93M
Supernus Pharmaceuticals SUPN:US $ 141.33M 10.4M
United Therapeutics UTHR:US $ 446.5M 67.4M
Vanda Pharmaceuticals VNDA:US $ 67.9M 5.23M
Zogenix ZGNX:US $ 18.79M 5.11M